Skip to Main Content

Author Details

Pablo Villoslada
Hospital Clinic of Barcelona-Institut d'Investigacions
1994
218
56
PMIDPaper TitleJournal TitlePublished Year
36864113Diffusion tensor imaging metrics associated with future disability in multiple sclerosis.Sci Rep2023
37573634Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.J Neuroimmunol2023
37782525Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD.J Neuroophthalmol2023
36810323Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2023
36864113Diffusion tensor imaging metrics associated with future disability in multiple sclerosis.Sci Rep2023
36991169A Phase 1 randomized study on the safety and pharmacokinetics of OCS-05, a neuroprotective disease modifying treatment for Acute Optic Neuritis and Multiple Sclerosis.Sci Rep2023
37782525Retinal Changes After Acute and Late Optic Neuritis in Aquaporin-4 Antibody Seropositive NMOSD.J Neuroophthalmol2023
37573634Immune cell subpopulations and serum neurofilament light chain are associated with increased risk of disease worsening in multiple sclerosis.J Neuroimmunol2023
36991169A Phase 1 randomized study on the safety and pharmacokinetics of OCS-05, a neuroprotective disease modifying treatment for Acute Optic Neuritis and Multiple Sclerosis.Sci Rep2023
36810323Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders.J Neurol Neurosurg Psychiatry2023
34711648Aquaporin-4-neuromyelitis optica spectrum disorder is not a progressive disease.J Neurol Neurosurg Psychiatry2022
36049213Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort.J Neuroophthalmol2022
35772194Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.Neuroimage Clin2022
35658739Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.Mult Scler2022
36038271Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease.Neurology2022
35764402The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.Neurology2022
35703428Longitudinal Retinal Changes in MOGAD.Ann Neurol2022
34711648Aquaporin-4-neuromyelitis optica spectrum disorder is not a progressive disease.J Neurol Neurosurg Psychiatry2022
35772194Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.Neuroimage Clin2022
35703428Longitudinal Retinal Changes in MOGAD.Ann Neurol2022
35764402The Role of Optical Coherence Tomography Criteria and Machine Learning in Multiple Sclerosis and Optic Neuritis Diagnosis.Neurology2022
35658739Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.Mult Scler2022
36038271Preventing Neurodegeneration in Multiple Sclerosis Is Required From the Earliest Stages of the Disease.Neurology2022
36049213Normative Data and Conversion Equation for Spectral-Domain Optical Coherence Tomography in an International Healthy Control Cohort.J Neuroophthalmol2022
33433258Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.Mult Scler2021
33910937APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies.Neurology2021
34271980Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.Genome Med2021
33838548Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients.Neuroimage Clin2021
33653903Seeing the Finish Line: Can Baseline OCT Values Predict Long-term Disability and Therapeutic Management in Multiple Sclerosis?Neurology2021
33974046In Vivo Molecular Changes in the Retina of Patients With Multiple Sclerosis.Invest Ophthalmol Vis Sci2021
33433258Oligoclonal IgM bands in the cerebrospinal fluid of patients with relapsing MS to inform long-term MS disability.Mult Scler2021
34612731Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?Mult Scler2021
34834459Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.J Pers Med2021
34413373Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients.Sci Rep2021
33910937APOSTEL 2.0 Recommendations for Reporting Quantitative Optical Coherence Tomography Studies.Neurology2021
33653903Seeing the Finish Line: Can Baseline OCT Values Predict Long-term Disability and Therapeutic Management in Multiple Sclerosis?Neurology2021
33838548Cortical fractal dimension predicts disability worsening in Multiple Sclerosis patients.Neuroimage Clin2021
34612731Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?Mult Scler2021
34834459Dynamics and Predictors of Cognitive Impairment along the Disease Course in Multiple Sclerosis.J Pers Med2021
34413373Regional grey matter microstructural changes and volume loss according to disease duration in multiple sclerosis patients.Sci Rep2021
34271980Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis.Genome Med2021
33974046In Vivo Molecular Changes in the Retina of Patients With Multiple Sclerosis.Invest Ophthalmol Vis Sci2021
31566686Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.JAMA Neurol2020
32139439Impact of treatment on cellular immunophenotype in MS: A cross-sectional study.Neurol Neuroimmunol Neuroinflamm2020
32299268New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis.Expert Opin Investig Drugs2020
31566686Using Acute Optic Neuritis Trials to Assess Neuroprotective and Remyelinating Therapies in Multiple Sclerosis.JAMA Neurol2020
32929024The immune signatures of multiple sclerosis: Lessons from twin studies.Proc Natl Acad Sci U S A2020
32747833Reclassifying neurodegenerative diseases.Nat Biomed Eng2020
32943770Author Correction: Reclassifying neurodegenerative diseases.Nat Biomed Eng2020
32723803Optical coherence tomography: A useful tool for identifying subclinical optic neuropathy in diagnosing multiple sclerosis.Neurology2020
  • 1 - 50 of 436

Recommended Authors

B??lint Kincses
Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen
Career Start Year 2017
Number of shared co-authors 0
Davide Poggiali
University of Padua
Career Start Year 2015
Number of shared co-authors 0
Spencer M Moore
University of Arizona College of Medicine
Career Start Year 2013
Number of shared co-authors 0
Wendy S Vargas
Columbia University Medical Center
Career Start Year 2012
Number of shared co-authors 3
Kathryn C Fitzgerald
Johns Hopkins University School of Medicine
Career Start Year 2012
Number of shared co-authors 9
Colin D Shea
Department of Emergency Medicine Vanderbilt University Medical Center Nashville TN.
Career Start Year 2011
Number of shared co-authors 1
Hugh Kearney
St. Vincent's University Hospital
Career Start Year 2007
Number of shared co-authors 1
Kristin M Galetta
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 11
Erin E Longbrake
Yale University
Career Start Year 2005
Number of shared co-authors 6
Tracy J Yuen
Genentech Inc.
Career Start Year 2005
Number of shared co-authors 1
Gregory Constantine
University of Pittsburgh
Career Start Year 2004
Number of shared co-authors 2
Zongqi Xia
University of Pittsburgh
Career Start Year 2003
Number of shared co-authors 2
Christopher Dirk Keene
University of Washington
Career Start Year 1998
Number of shared co-authors 7
Stephen W Reddel
Concord Repatriation General Hospital
Career Start Year 1998
Number of shared co-authors 10
Steven M Greenberg
Massachusetts General Hospital
Career Start Year 1993
Number of shared co-authors 6
Yuko Shimizu
Tokyo Women's Medical University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Michael K Racke
The Ohio State University Wexner Medical Center
Career Start Year 1991
Number of shared co-authors 10
Murali Ramanathan
Department of Pharmaceutical Sciences, State University of New York
Career Start Year 1991
Number of shared co-authors 2
Jian-Qiang Lu
McMaster University
Career Start Year 1991
Number of shared co-authors 0
Charlie Davie
Royal Free Hospital
Career Start Year 1991
Number of shared co-authors 1
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 1
James D Bowen
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 11
David Leppert
Biomedicine and Clinical Research, University Hospital Basel, University of Basel
Career Start Year 1985
Number of shared co-authors 12
Dennis L Kolson
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1985
Number of shared co-authors 2
Matthew P Frosch
Massachusetts General Hospital and Harvard Medical School
Career Start Year 1984
Number of shared co-authors 9
David B Clifford
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 3
Paul M Matthews
UK Dementia Research Institute Centre at Imperial College London
Career Start Year 1981
Number of shared co-authors 14
Gary Cutter
University of Alabama at Birmingham
Career Start Year 1976
Number of shared co-authors 18
Lawrence S Honig
University of California
Career Start Year 1975
Number of shared co-authors 8
Guy M McKhann
New York Presbyterian Hospital, Columbia University Medical Center
Career Start Year 1959
Number of shared co-authors 3

Collaborators

Elena H Martinez-Lapiscina
Fundacio Recerca Clinic Barcelona -IDIBAPS
Co-authored papers 46
Xavier Montalban
Co-authored papers 30
Friedemann Paul
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 27
Jorge Sepulcre
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Co-authored papers 25
Axel Petzold
Moorfields Eye Hospital
Co-authored papers 13
Alexander U Brandt
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 12
Laura J Balcer
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 11
Stephen L Hauser
Co-authored papers 11
Manuel Comabella
Co-authored papers 11
Jorge R Oksenberg
Co-authored papers 11
Lisanne J Balk
Vrije Universiteit Amsterdam
Co-authored papers 10
Sergio E Baranzini
University of California san francisco
Co-authored papers 10
Peter A Calabresi
Johns Hopkins University School of Medicine
Co-authored papers 9
Letizia Leocani
Vita-Salute University & Hospital San Raffaele
Co-authored papers 9
Hanna Zimmermann
Max-Delbruck Center for Molecular Medicine in the Helmholtz Association
Co-authored papers 9
Elliot M Frohman
Stanford University School of Medicine
Co-authored papers 8
Shiv Saidha
Johns Hopkins University School of Medicine
Co-authored papers 8
Steven L Galetta
Department of Neurology and NYU Grossman School of Medicine
Co-authored papers 8
Teresa C Frohman
Stanford University School of Medicine
Co-authored papers 7
Roland Martin
Co-authored papers 7
Joachim Havla
Institute of Clinical Neuroimmunology, LMU Hospital, Ludwig Maximilians University
Co-authored papers 7
Hanne F Harbo
Co-authored papers 7
Jean Pelletier
Co-authored papers 6
Tomas Olsson
Co-authored papers 6
Lisa F Barcellos
Co-authored papers 6
Marco Pisa
Oxford University
Co-authored papers 6
Benjamin Knier
Technical University of Munich
Co-authored papers 6
Thomas Korn
TUM School of Medicine, Technical University of Munich
Co-authored papers 5
Stephen Sawcer
Co-authored papers 5
Scott S Zamvil
Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 5
Release 1.2